Innovative Diagnostics for Public Health

InBios International develops and manufactures highly sensitive and specific immunodiagnostics for infectious diseases.

Our purpose is to serve the global marketplace with accurate, superior quality products that are easy to use and cost effective.

Read More

InBios’ Zika IgM ELISA receives market authorization from FDA!

DENV NS1 Final 340

InBios receives the first FDA market authorization for its diagnostic test for detecting Zika virus IgM antibodies. Available now. InBios Press Release

Read More

Conference Exhibitions

AACC, August 4-8, 2019, Anaheim, CA, Booth 4309

ASM Biothreats, January 29-31, 2019, Arlington, VA, Booth 26

Zika   •   Chikungunya   •   Dengue   •   West Nile   •   Japanese Encephalitis   •   Scrub Typhus   •   Visceral Leishmaniasis   •   Cutaneous Leishmaniasis   •   Chagas   •   Filariasis   •   Strongyloides   •   Leptospirosis   •   Melioidosis   •   Norovirus

Current Newsletter
View Past Newsletters
Sign Up for InBios Email